Press Release

MeDiNova is a fast-growing network of 33 active clinical research sites in key markets in Europe and Africa. Founded in 2000, the company has experience operating a number of different site models, including dedicated research sites, integrated research sites and working with third party affiliate sites. MeDiNova Research sites have a proprietary database of 400,000 patients and interested potential study participants and have access to over 5 million patients via electronic medical records through strong healthcare partnerships.

NASDAQ listed ICON plc is a global provider of drug and device development and commercialisation services to pharmaceutical, biotechnology and medical device industries. The acquisition of MeDiNova further enhances Dublin-based ICON’s patient recruitment capabilities in EMEA and compliments ICON’s existing site network in the US.

Kumar Muthalagappan OBE, Chief Executive Officer of MeDiNova Research said “ICON provides MeDiNova with a great opportunity for continued growth through scaling our knowledge, infrastructures and healthcare relationships. The MeDiNova-ICON combination will further enhance our highly productive models to deliver the ‘best in class sites performance’ for the industry.”

Partner Simon Ward and Manager Matthew Guest advised the shareholders of MeDiNova on the transaction. Simon Ward commented “MeDiNova is an outstanding UK success story. The business has seen strong growth over recent years and we worked with the shareholders over a long period to prepare for the next stage of its development. ICON is a global player and this strategic acquisition represents a great outcome for all.”

THE CLIENT ON SPRINGBOARD
"Springboard worked alongside my fellow shareholders and I for a number of years to prepare and position MeDiNova. Ours was a fast growing global business that was attractive to a number of international players. The experienced, straightforward advice of Springboard was invaluable in the ultimate delivery of the transaction.” -- Kumar Muthalagappan OBE, Chief Executive Officer - MeDiNova Research

ABOUT SPRINGBOARD
We are a market leading corporate advisory firm focused on providing strategic, commercial and financial advice and support to a range of clients. We focus exclusively on the following services:

• Acquisitions - supporting corporates and management teams – identifying targets and executing deals
• Disposals - Full or partial business sales and exits
• Raising finance - working capital or development capital – typically debt or private equity/venture capital
• Management / Retained advisory - strategic, commercial and financial support